drug

Retrospective study of frozen samples

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
GENETIC
Pre-approval / investigational in the US
Developed by Fundación Marques de Valdecilla
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
GENETIC

Indications

Trials

1
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients
NCT02897167—Completed

KOLs & investigators

1
Benedicto Crespo-Facorro, ProfessorKOL score 12

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Fundación Marques de Valdecilla
company
trial
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients
trial
indication
Schizophrenia
indication
Mental Disorders
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Mental Disorders
indication
KOL
Benedicto Crespo-Facorro, Professor
KOL score 12
person